If You Invested $10,000 in Novavax in 2020, This Is How Much You Would Have Today
Novavax (NASDAQ: NVAX) has been a volatile stock over the past few years. From optimism around its COVID-19 vaccine to concerns about delays, it has sent its investors on a roller-coaster ride. Early investors are sitting on some incredible returns right now, but those who bought early on this year when the stock was trading at more than $300 have incurred steep losses.
I'll look back at how you would have done in 2020 if you had bought at different months, and how early you would have needed to get in on the stock to earn a great return. And, most importantly, I'll assess whether the stock worth buying today.
Image source: Getty Images
Source Fool.com
